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Background: Uterine fibroid is the most common tumor of the female genital tract. The benign tumors often grow into large 
sizes and assume unsightly shapes with concomitant symptoms and signs. Being a predominantly reproductive age disease, 
concurrent infertility and symptomatic uterine fibroids pose management challenges. Individualization of the patient is thus 
essential to the success of the reproductive outcome.
Objectives: This study determined the prevalence, trend, management modalities, pregnancy outcome, and exposition of 
factors affecting pregnancy outcome among patients presenting with uterine fibroids and infertility at the Obafemi Awolowo 
University Teaching Hospitals Complex (OAUTHC).
Materials and Methods: This is a retrospective study of case records of 106 women managed for uterine fibroids and infertility 
over a 5‑year period (January 1, 2012, to December 31, 2016) at the OAUTHC. The outcome measure is the pregnancy rate 
among those who had a myomectomy.
Results: About a quarter of women with infertility had symptomatic uterine fibroids and this represents about 35%–40% 
of the overall number of women presenting as uterine fibroid within the study. About 84.9% had uterine size >12 weeks at 
presentation. Two‑third of the patients had open myomectomy alone with 43.9% achieving conception thereafter. Conception 
rate for myomectomy with tuboplasty was 31.3% whereas myomectomy with subsequent in vitro fertilization (IVF) was 50%. 
Pregnancy rate decreased with increasing size of the uterus before myomectomy.
Conclusion: Symptomatic fibroid was significantly prevalent among women with infertility. Myomectomy improves fertility 
potential and success rate of IVF. Uterine fibroid has both direct and indirect effect on infertility and pregnancy rate in this 
group of the patient can be improved through routine screening for uterine fibroids and early removal of the fibroids before 
they grow into giants size.
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Introduction
Uterine fibroids are the most common tumors of the 
uterus and female pelvis.[1-3] The true incidence of fibroids 
is unknown in our environment as many affected women 
are asymptomatic. They are estimated to occur in 20%–50% 
of women with increased frequency during the later 
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reproductive years causing significant morbidity and 
reproductive ill-health. In fact, they are said to be present in 
as many as 70% of uteri removed at hysterectomy while some 
ultrasound studies have indicated the presence of at least one 
small myoma in 51% of women.[3,4] Previously documented 
prevalence of uterine fibroids in Nigeria were hospital based 
with varying denominators thereby not reflecting the true 
prevalence of uterine fibroids in the country. Prevalence of 
9.8% (Lokoja), 7.8% (Ilesa), 8.3% (Zaria), and 6.58% from Ile-Ife 
in various studies have been reported.[4-11]
Uterine fibroids are 3–9 times more common among black 
women of African descent than in Caucasians which indicates 
a strong association between race and ethnicity.[1,2] They 
are very common among the nulliparous or those having 
one-child or infertility and are associated with increased 
incidence of pregnancy loss.[12,13] The clinical presentation 
of fibroids are variable and this depends on the size and 
number of fibroids and the location of the fibroids within 
the uterus. However, majority are incidental findings during a 
clinical or ultrasound examination and hence asymptomatic. 
Most symptomatic patients present with abdominal swelling, 
abdominal discomfort, abnormal uterine bleeding, infertility, 
and pressure symptoms and they grow to very large sizes 
in Negroid women than their Caucasian counterparts.[4-6,11]
A significant number of patients with uterine fibroids 
have infertility component in their presentations.[5-7,10,11] 
Symptomatic uterine fibroid with infertility poses management 
challenges, particularly in the young women of reproductive 
age group. Management strategies are usually individualized 
based on the associated symptoms other than the difficulty in 
getting pregnant, size and location of the fibroids, co-existing 
pelvic pathology, patient’s age and the socio-economic status 
of many of these patients.
This study audits the contribution and pregnancy outcome 
of patients with uterine fibroids among the infertile women 
attending the gynecological clinic of the Obafemi Awolowo 
University Teaching Hospitals Complex (OAUTHC) with a view 
to determining prevalence, trend, management, pregnancy 
outcome, and exposition of factors limiting pregnancy 
outcome among patients presenting with uterine fibroids 
and infertility over a 5-year period.
Materials and Methods
All cases of uterine fibroids with infertility diagnosed in 
OAUTHC Ile-Ife gynecological clinic medical record register 
from January 1, 2012, to December 31, 2016, were reviewed. 
The case notes of 106 of these patients were available for 
analysis from the computerized records of the medical records 
department. The case notes were studied, and data related 
to the patient’s age, parity, occupation, clinical features, 
mode of treatment, and pregnancy outcome were collected 
and analyzed. The total number of patients presenting with 
fibroids and infertile women presenting yearly from 2012 to 
2016 were also retrieved. All the 106 patients who constituted 
the focus of the study over the years reviewed were admitted 
after obtaining full history, physical examination, relevant 
investigations to identify the other factors of infertility before 
surgery. The data so obtained were stored, retrieved, and 
analyzed using Statistical Package for Social Science Version 
20; (Chicago II, USA).
Results
There were 420 cases of infertility seen during the 5-year 
study while those who were diagnosed with fibroid with 
infertility were 106. This represents 25.2% of all cases of 
infertility [Table 1]. The medical record register revealed a 
total of 268 cases of uterine fibroids seen during the period, 
but those who presented themselves for further treatment 
were 193. Of these 193 actively managed fibroid cases were 
106 patients diagnosed with fibroid with infertility representing 
54.9% of cases of uterine fibroids managed from 2012 to 2016.
Table 2 shows that uterine fibroids occur more in low-parity 
women and can attain very big sizes and apart from 
infertility, there are varied concomitant symptoms that may 
be associated with infertility.
Forty-two pregnancies were recorded among the 106 patients 
giving an overall pregnancy rate of 39.6%.
Table 4 shows that the prognosis for pregnancy outcome 
decreases with increasing size of the uterus containing 
the fibroids. Better pregnancy rates are observed when 
Table 1: Trends of the number of women with infertility, uterine 
fibroids and patients with uterine fibroid and infertility between 
2012 and 2016 in Ife State Hospital
2012 2013 2014 2015 2016 Total
Total number of women with 
infertility
68 84 84 90 94 420
Total number of women with fibroid 
seen at the clinic
48 53 49 56 62 268
Total number of women treated for 
fibroid
30 38 35 43 47 193
Total number of women treated 
with fibroid and infertility
17 20 22 23 24 106
Percentage of women with fibroid 
and infertility to the overall infertility
25 23.8 26.2 25.6 25.3 25.2
Percentage of women with 
fibroid and infertility to the 
overall number of uterine fibroids 
seen
35.4 37.7 44.9 41.1 38.7 39.6
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the uterine size is <20 weeks pregnant uterus and this is 
statistically significant (P < 0.002).
Discussion
Uterine fibroid was prevalent among patients with infertility 
in this review as about a quarter of them (25.2%) had uterine 
fibroids that warranted active management. This figure is 
higher than 10% reported by Cook et al.[14] and the reason 
for this may be due to the lower incidence of fibroids in the 
population. The relationship between uterine fibroids and 
infertility has been theorized to either be causal or casual.[15] 
The discourse on fibroid negatively affecting fertility or 
pregnancy being a protective factor against the occurrence 
of uterine fibroids remains an important area of research. 
There was an increasing trend in the number of women seen 
with uterine fibroids and infertility in successive years over 
the study period [Table 1]. This may not be unconnected 
to different presentations of major and minor symptoms 
exhibited by these subsets in Table 2 and which have been 
long documented in other studies.[4-11]
Majority of the patients were within the age range of 
30–49 years. This is in agreement with similar studies in 
Nigeria.[16-19] Three out of every five of the women with fibroid 
and infertility were nulliparous. This finding is higher than 
that reported by Ekine et al., in their review of the clinical 
presentation of uterine fibroids and the effect of therapeutic 
intervention on fertility.[20] The effect of prolonged estrogen 
exposure, as exemplified in nulliparous women, on uterine 
fibroid occurrence and growth is well established.[6] Estrogen 
enhances tissue response to progesterone while progesterone 
causes immortalization of the smooth muscle cells resulting 
in the development and growth of fibroid.
Notably,	giant	fibroids	of	≥30	week	size	were	found	in	7.5%	
of the patients. Distorted and inaccurate health information 
among the populace may contribute to late presentation 
when complications have set in or the fibroids become 
huge.[21] Menstrual abnormalities and abdominal swelling 
remained the leading presenting complaints as found in 
67.9% and 58.3% of the patients. This is consistent with 
findings from several studies on the symptomatology of 
uterine fibroids.[6,16,18,20,22] Menorrhagia may result from the 
increased endometrial surface area, vascular congestion 
causing increased uterine bleeding, prostaglandin imbalance 
in favor of vasodilators, and poor myometrial contractility. 
Menorrhagia leading to anemia, infection, weakness, and 
poor health together with abdominal pains and abdominal 
distention cause profound morbidity in fibroids which 
also worsens the outcome of infertility in those having the 
combined tragedy [Tables 2-4].
Table 2: Age, parity, uterine size, and symptomatology among 
106 patients with fibroids and associated infertility (2012‑2016) 
in Ile‑Ife




























Abdominal swelling 57 (53.8)
Abdominal pains 21 (19.8)
Recurrent abortion 12 (11.3)
Hypertension 10 (9.4)
Menopausal symptoms 6 (5.7)
Hemoconcentration 8 (7.5)
Leg swelling 5 (4.7)
Others (dyspareunia, constipation, urinary 
obstruction, etc.,)
10  (9.4)
Table 3: The treatment offered and pregnancy outcome among 
106 patients with fibroid and associated infertility in Ile‑Ife, 
2012‑2016
Treatment offered n (%) Pregnancy outcome (%)
Abdominal myomectomy 66 (62.3) 29 (43.9)
Myomectomy + tuboplasty 
(salpingolysis)
16 (15.1) 5 (31.3)
Myomectomy + ovarian 
cystectomy
7 (6.6) 2 (28.6)





3 (2.8) 1 (33.3)
Myomectomy + IVF‑ET 10 (9.4) 5 (50.0)
Total abdominal hysterectomy 2 (1.9) ‑
Total 106 (100) 42  (39.6)
IVF‑ET, In vitro fertilization‑embryo transfer
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Open myomectomy was offered to two-third of the patients, 
and of these patients, 43.9% had achieved conception as at 
the time of this report. This is comparable to 49% reported by 
Donnez and Jadoul[23] but lower than postsurgical pregnancy 
rate of 57% reported by Somigliana et al.[24] Despite the 
attendant myometrial trauma and risk of adhesion formation 
following myomectomy, it is generally believed that fertility 
improves following the removal of uterine fibroids. Bulletti et 
al., conducted a study to evaluate the effect of myomectomy 
on fertility using three groups of patients numbering 106 
in each group-a set of patients who had laparoscopic 
myomectomy, another set with fibroid that was not removed 
and the third group with unexplained infertility without 
coexisting fibroid. After 9 months of follow-up, pregnancy 
and favorable outcome were significantly recorded among 
the treatment group.[25] In the absence of other causes of 
infertility, myomectomy is advised in patients with infertility 
and coexisting symptomatic myoma.
The pregnancy rate of 31% following myomectomy and 
tuboplasty which is lower than the 50% recorded following 
in vitro fertilization (IVF) may further reinforce the relatively 
limited benefit of tubal surgeries in patients with infertility. 
However, tubal reconstruction surgeries may still have a place 
in our society where the financial implication of IVF may make 
it unaffordable for many couples. Improved outcome of IVF 
after myomectomy has been researched and established. 
The presence of uterine fibroid, especially, submucous 
fibroid prevents apposition of the developing embryo to the 
endometrium, hampers its adhesion and limits the invasion 
of trophoblasts in the tightly-regulated period regarded as 
the “window of implantation.” Thus without myomectomy, 
embryo transfer is unlikely to result in eventual pregnancy.[26]
The pregnancy rate decreased with increasing size of the 
uterine fibroid, such that the chance of conception for 
uterus that is not palpable par abdomen is three times that 
of the uterine size of 30 weeks or more. This highlights 
the importance of seeking care as soon as possible before 
huge fibroids develop. Fibroid, especially when huge, could 
contribute to subfertility by endometrial cavity distortion, 
elongation of distance to be traveled by the spermatozoa 
to reach the site of fertilization, suboptimal endometrial 
vascularization and incoordinate uterine muscle action 
culminating in poor gamete transfer. Cervical fibroid and 
degenerative changes may limit the frequency of coitus due 
to dyspareunia and mechanical blockage of tubal ostium at 
the cornu by fibroids in the body or fundus of the uterus may 
block gamete transfer.[25]
Conclusion and Recommendations
Uterine fibroid is thus a common finding among patients with 
infertility and quite a majority of them have poor pregnancy 
rate following myomectomy (60.4%). While it is preponderant 
in the active reproductive age, nulliparity remains an 
important risk factor. Late presentation with very huge 
uterine fibroids is still found in our environment. Surgical 
treatment offers improvement in reproductive outcome and 
enhances the success rate of IVF. Impalpable fibroids offer a 
better prognosis in reproductive outcome than those that are 
palpable par abdomen. It is therefore imperative to screen for 
uterine fibroids early and treat among the cohorts of infertile 
woman to improve fertility potential and pregnancy outcome. 
All women in the reproductive age group need a pelvic 
scan to detect submucous, cornual, and intraligamentous 
fibroid that can compromise the reproductive outcome in 
the Nigerian/African environment where the prevalence of 
uterine fibroid is highest.
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